Leading players in Spirometers Market
The spirometers market is expected to reach USD 1,047 million by 2023 from USD 655 million in 2018, at a CAGR of 9.8%. Market growth is largely driven by the rising global incidence of respiratory diseases, global population, and technological advancements in spirometer devices. Opportunities for growth of the market exist in emerging economies on account of increasing pollution levels and rising awareness regarding COPD and other respiratory conditions. On the other hand, the time required to carry out tests using spirometers and data accuracy issues associated with personalized spirometers are expected to limit market growth during the forecast period.
The spirometers market is highly consolidated in nature, with a few players offering a variety of products. The major players operating in this market are Hill Rom (US), Vyaire Medical (US), Fukuda Sangyo (Japan), Chest MI (Japan), Schiller AG (Switzerland), MGC Diagnostics (US), Medical International Research (Italy), NDD Medical Technologies (Switzerland), Vitalograph (UK), and MidMark Corporation (US).
The key strategies followed by most companies in the spirometers market are product launches and partnerships. These two strategies accounted for the largest share of the overall growth strategies mapped from 2015 to 2018.
Comments
Post a Comment